Compare Eli Lilly And Co (LLY) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Verizon Communications Inc — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Verizon Communications Inc trades at $41.65 (market cap $192.57B). The key difference: Eli Lilly And Co is far larger — about 5.4× Verizon Communications Inc's market cap, and Verizon Communications Inc pays the higher dividend (6.11%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Verizon Communications Inc for 109 Days on average.
| LLY | VZ | |
|---|---|---|
Market Cap | $1.04T | $192.57B |
Volume | 3,064,878 | 20,940,094 |
Sector | Health | Media |
52-Week High | $1.28K | $51.45 |
52-Week Low | $799.57 | $38.40 |
Typical Hold Time | 93 Days | 109 Days |
Enterprise Value | $1.09T | $379.28B |
Dividend Yield | 0.59% | 6.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.
LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.
Verizon (VZ) trades at $46.35, up 1.27% today, with a bearish technical signal despite recent earnings beats. The stock shows stable revenue around $138B annually with strong cash flow generation of $37.1B from operations in 2025. Valuation metrics appear reasonable with P/E of 12.07 and EV/EBITDA of 7.9, while the company maintains a solid dividend yield supported by consistent cash flows.
Outlook remains stable with moderate growth prospects amid competitive telecom landscape. Investment appeal centers on dividend reliability and defensive positioning, though technical weakness and modest revenue growth present near-term challenges. Risks include intense competition and capital expenditure requirements for network expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
